[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100355051":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":30,"responsibleParty":45,"collaborators":20,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":20,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":20,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"prednisolone","EXPERIMENTAL","prednisolone oral 10 mg\u002Fday from day one of the subsequent menstrual cycle to day LH plus 7. Women will be then given a tailing off dose of 5 mg\u002Fday for 3 days followed by 2 mg\u002Fday for 3 days and then 1 mg\u002Fday for 3 days.",[13],"Drug: Prednisolone",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Prednisolone","prednisolone oral 10 mg\u002Fday from day one of the subsequent menstrual cycle to day LH 7 of that cycle. Then, the participants will be given a tailing off dose of 5 mg\u002Fday for 3 days followed by 2 mg\u002Fday for 3 days and then 1 mg\u002Fday for 3 days.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Stacey Wong, BSc","CONTACT","85235051764","staceywong@cuhk.edu.hk",{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},"Pui Wah Jacqueline Chung, MBBS","jacquelinechung@cuhk.edu.hk",[31],{"facility":32,"status":33,"city":34,"state":20,"zip":20,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"The Chinese University of Hong Kong","RECRUITING","Hong Kong","HK",{"type":37,"coordinates":38},"Point",[39,40],114.17469,22.27832,{"lat":40,"lon":39},[43,44],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Chung Pui Wah Jacqueline","Associate Professor","100355051","phase-3-effect-of-prednisolone-treatment-on-uterine-natural-killer-cells-100355051",false,"NCT03902912","Effect of Prednisolone Treatment on Uterine Natural Killer Cells","Effect of Prednisolone Treatment on Uterine Natural Killer Cells and Endometrial Angiogenesis in Recurrent Miscarriage Around the Time of Embryo Implantation","Inclusion Criteria:\n\n1. Women with a history of 3 or more consecutive miscarriages\n2. Women younger than 40 years old\n\nExclusion Criteria:\n\n1. Allergy to prednisolone\n2. Women who have any uterine anomaly\n3. Antiphospholipid syndrome\n4. Hydrosalpinx\n5. Thrombophilia\n6. Abnormal thyroid function tests\n7. women with diabetes,",true,"FEMALE","18 Years","40 Years",{"count":61,"type":62},84,"ESTIMATED","INTERVENTIONAL",[65],"PHASE3","This study aims to investigate the role of uNK cells and the association with prednisolone.",[68],"Recurrent Miscarriage",[70,71],"recurrent miscarriage","prednisolone treatment","2025-03-19",{"date":74,"type":75},"2025-03-21","ACTUAL",{"date":77,"type":75},"2019-07-30",{"date":79,"type":62},"2028-04-30",{"name":5,"class":6},1]